1H09 Catalysts for 4 Healthcare Stocks [View article]
The prime time of investment opportunities for the so called: TECHNOLOGY sector, namely computer/network/inter... and personal devices and enterprise software(ERP) was long gone.
The next big thing coming is stem cell based regenerative medicine, this is a huge field as big as TECHNOLOGY if not bigger. From the hardware(tools) to treatments to drugs, this is the golden opportunity for those who do some study, dig in further, a lot have been going on yet a lot more will be happening as the new year unfolds especially in "adult stem cell" area.
Investment in tools, treatments or drugs now is like investment in TECHNOLOGY a decade ago in hardware, software and internet/mobile devices.
Investment in stem cell exectraction/preservat... tools is the safest and the 1st to be rewarded, then treatments and then in drugs. Treatments and drugs will have the biggest winfall but they are further down the pipeline in terms of timing.
Disclosure: long tool stock (KOOL), lurk on a few stocks in treatment and drug with stem cell/regenerative medicine flavor.
-
The prime time of investment opportunities for the so called: TECHNOLOGY sector, namely computer/network/inter... and personal devices and enterprise software(ERP) was long gone.
Jan 09 00:29 am
|Rating:
0
0
All Comments by stox2buy »1H09 Catalysts for 4 Healthcare Stocks [View article]
The next big thing coming is stem cell based regenerative medicine, this is a huge field as big as TECHNOLOGY if not bigger. From the hardware(tools) to treatments to drugs, this is the golden opportunity for those who do some study, dig in further, a lot have been going on yet a lot more will be happening as the new year unfolds especially in "adult stem cell" area.
Investment in tools, treatments or drugs now is like investment in TECHNOLOGY a decade ago in hardware, software and internet/mobile devices.
Investment in stem cell exectraction/preservat... tools is the safest and the 1st to be rewarded, then treatments and then in drugs. Treatments and drugs will have the biggest winfall but they are further down the pipeline in terms of timing.
Disclosure: long tool stock (KOOL), lurk on a few stocks in treatment and drug with stem cell/regenerative medicine flavor.